PDF
T/GMIAAC 003-2024 Active
T/GMIAAC 003-2024 Management and standardization of diagnostic and therapeutic guidelines for abnormal liver function related to endocrine and metabolic diseases
Abstract
This document stipulates the screening assessment, diagnosis, treatment, prognosis evaluation, and preventive intervention for liver dysfunction related to endocrine and metabolic diseases.
This document is applicable to guiding the screening, diagnosis, treatment, and prevention of liver dysfunction in people aged 7 and above with endocrine and metabolic diseases.
General Product Information
| Document Type | Group standards |
|---|---|
| Standard Status | Active |
| Standard Code | T/GMIAAC 003-2024 |
| CCS | Urban transportation facilities |
| ICS | Integrated medical science and healthcare devices |
| Implement Date | 2024-01-19 |
Price
$ 65.00
Subtotal
$ 65.00
Tax
$ 0.00
Order Total (incl. tax)
$ 65.00